We are live on ! Find out more
GC

GMT Capital Portfolio holdings

AUM $2.19B
1-Year Est. Return 72.3%
This Fund
S&P 500
This Quarter Est. Return
+21.43%
1 Year Est. Return
+72.3%
3 Year Est. Return
+172.46%
5 Year Est. Return
+183.05%
10 Year Est. Return
+942.8%
AUM
$2.39B
AUM Growth
+$506M
Cap. Flow
+$177M
Cap. Flow %
7.39%
Top 10 Hldgs %
65.92%
Holding
77
New
8
Increased
10
Reduced
16
Closed
6

Top Buys

Rank Stock Value
1
HBM icon
Hudbay
HBM
+$266M
2
CBRL icon
Cracker Barrel
CBRL
+$40.6M
3
C icon
Citigroup
C
+$36.4M
4
MOS icon
The Mosaic Company
MOS
+$32.6M
5
BDX icon
Becton Dickinson
BDX
+$16.6M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$74M
2
VRN
Veren
VRN
+$47.3M
3
BABA icon
Alibaba
BABA
+$30.2M
4
LNTH icon
Lantheus
LNTH
+$23.1M
5
KD icon
Kyndryl
KD
+$19.1M

Sector Composition

Rank Sector Weight
1 Materials 27.39%
2 Consumer Discretionary 22.49%
3 Industrials 17%
4 Technology 15.54%
5 Communication Services 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRIP icon
76
TripAdvisor
TRIP
$1.68B
-570,300
Closed -$8.08M
VRN
77
DELISTED
Veren
VRN
-7,152,756
Closed -$47.3M

Similar funds

GMT Capital's Q2 2025 Portfolio in Review

As of Q2 2025, GMT Capital held 77 positions worth $2.39B, up 27% from $1.88B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

GMT Capital deployed $177M of net new capital in Q2 2025, opening 8 new positions and adding to 10 existing holdings. Its largest new stake was Hudbay: 31,899,020 shares worth $338M.

By sector, the portfolio is most concentrated in Materials at 27% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Alibaba, an estimated $30.2M trimmed.

  • GMT Capital's largest Q2 2025 buy was Hudbay: 31,899,020 shares worth $338M.
  • GMT Capital added most to Cracker Barrel in Q2 2025, an estimated $40.6M increase.
  • GMT Capital's biggest Q2 2025 reduction was Alibaba, cutting an estimated $30.2M.
  • GMT Capital fully exited Royalty Pharma in Q2 2025, selling an estimated $74M.
  • GMT Capital's ten largest holdings make up 66% of its $2.39B portfolio in Q2 2025.
  • GMT Capital opened 8 new positions and closed 6 in Q2 2025.
  • GMT Capital's portfolio value rose 27% quarter-over-quarter to $2.39B.

Based on GMT Capital's 13F filing for Q2 2025, filed 14 Aug 2025.